| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 6.59e-10 | 38 | 163 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.39e-07 | 118 | 163 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 6.14e-06 | 85 | 163 | 7 | GO:0017018 | |
| GeneOntologyMolecularFunction | calcium ion binding | PITPNM2 DCHS2 FAT4 MASP1 PCDHGA1 PCDHB7 PCDHB6 CDH23 ADGRV1 PKD1L3 ITPR3 FAT2 SULF2 CDH20 HMCN2 SULF1 CPNE1 FER1L5 CDH8 | 1.21e-05 | 749 | 163 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 2.58e-05 | 189 | 163 | 9 | GO:0004721 | |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 3.15e-05 | 109 | 163 | 7 | GO:0004722 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.18e-04 | 230 | 163 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat phosphatase activity | 1.44e-04 | 13 | 163 | 3 | GO:0008420 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH3 MYH4 MYH8 CEACAM5 MYH13 TRPC6 MTSS1 CEACAM6 MYO3B MICAL3 MYO15A | 1.59e-04 | 479 | 163 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | protein farnesyltransferase activity | 1.98e-04 | 3 | 163 | 2 | GO:0004660 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine-6-sulfatase activity | 1.98e-04 | 3 | 163 | 2 | GO:0008449 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | MYH3 MYH8 DUSP7 SMPD4 CTDSP1 PTPN22 PTPN21 CTDSP2 MPPED2 CTDSPL PPTC7 | 3.40e-04 | 386 | 163 | 11 | GO:0042578 |
| GeneOntologyMolecularFunction | ErbB-2 class receptor binding | 3.93e-04 | 4 | 163 | 2 | GO:0005176 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.66e-04 | 227 | 163 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | phosphatase activity | 6.01e-04 | 287 | 163 | 9 | GO:0016791 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat modifying activity | 8.39e-04 | 23 | 163 | 3 | GO:0140994 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 9.88e-04 | 372 | 163 | 10 | GO:0061630 | |
| GeneOntologyMolecularFunction | deubiquitinase activator activity | 1.35e-03 | 7 | 163 | 2 | GO:0035800 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.42e-03 | 149 | 163 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.63e-03 | 398 | 163 | 10 | GO:0061659 | |
| GeneOntologyMolecularFunction | protein prenyltransferase activity | 1.80e-03 | 8 | 163 | 2 | GO:0008318 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 1.80e-03 | 8 | 163 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | protein domain specific binding | RIPK1 MAP4K3 TRIM65 PTPN22 GRIK5 SIRPA FOXA1 FOXA3 SIT1 ARHGAP5 JUN UBR5 NFE2 PKD1 ADGRL2 SHISA6 | 2.19e-03 | 875 | 163 | 16 | GO:0019904 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 FAT4 CEACAM5 PCDHGA1 PCDHB7 PCDHB6 CDH23 CEACAM6 FAT2 CDH20 HMCN2 PKD1 CDH8 | 2.34e-09 | 187 | 159 | 13 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 FAT4 CEACAM5 PCDHGA1 PCDHB7 PCDHB6 CDH23 CEACAM6 FAT2 CDH20 HMCN2 PKD1 FLRT3 CDH8 | 1.50e-07 | 313 | 159 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | nephron development | DCHS2 AMPD2 FAT4 ERBB4 MTSS1 TFAP2B TGFB1 GREB1L SULF2 SULF1 | 1.02e-06 | 174 | 159 | 10 | GO:0072006 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 FAT4 CEACAM5 PCDHGA1 PCDHB7 PCDHB6 CDH23 CEACAM6 PTPN22 SIRPA ADGRV1 FOXA1 TGFB1 FAT2 CD5 CDH20 HMCN2 PKD1 ADAMTS18 CERCAM FLRT3 MUC4 CDH8 IL23R | 2.68e-06 | 1077 | 159 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 4.34e-06 | 15 | 159 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FAT4 ERBB4 TBX4 CEACAM5 KAT6A OSR2 CDH23 CEACAM6 FOXA1 TGFB1 GREB1L ENAM JUN HOXB3 SULF2 ALMS1 SULF1 MYO3B PKD1 SNAI1 FGR CSMD1 MYO15A EMX1 EMX2 CSGALNACT1 | 4.54e-06 | 1269 | 159 | 26 | GO:0009887 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 9.56e-06 | 18 | 159 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | renal system development | DCHS2 AMPD2 FAT4 ERBB4 MTSS1 OSR2 TFAP2B TGFB1 GREB1L SULF2 SULF1 PKD1 EMX2 | 9.68e-06 | 386 | 159 | 13 | GO:0072001 |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.84e-05 | 21 | 159 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.84e-05 | 21 | 159 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | ERBB4 CEACAM5 TANK RIPK1 FNTA TRPC6 DUSP7 CEACAM6 CTDSP1 TAB2 TRIM65 PTPN22 SIRPA HUWE1 GPRC5A CTDSP2 TGFB1 JUN LRRN3 NFE2 PAXIP1 KNDC1 MINAR1 FGR CTDSPL IL23R BORA | 2.62e-05 | 1488 | 159 | 27 | GO:0031399 |
| GeneOntologyBiologicalProcess | kidney development | DCHS2 AMPD2 FAT4 ERBB4 MTSS1 OSR2 TFAP2B TGFB1 GREB1L SULF2 SULF1 PKD1 | 3.28e-05 | 372 | 159 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 5.44e-05 | 53 | 159 | 5 | GO:0060122 | |
| GeneOntologyBiologicalProcess | esophagus smooth muscle contraction | 5.91e-05 | 2 | 159 | 2 | GO:0014846 | |
| GeneOntologyBiologicalProcess | connective tissue development | OSR2 FOXA1 TGFB1 HOXB3 SULF2 SULF1 PKD1 PAXIP1 SNAI1 CSGALNACT1 RASAL2 | 7.42e-05 | 343 | 159 | 11 | GO:0061448 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | ERBB4 ABCA3 CEACAM5 RIPK1 TRPC6 DUSP7 CEACAM6 CTDSP1 TAB2 TRIM65 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN LRRN3 SMG7 JMJD8 KCTD20 KNDC1 FGR CTDSPL IL23R BORA | 8.91e-05 | 1421 | 159 | 25 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | ERBB4 ABCA3 CEACAM5 RIPK1 TRPC6 DUSP7 CEACAM6 CTDSP1 TAB2 TRIM65 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN LRRN3 SMG7 JMJD8 KCTD20 KNDC1 FGR CTDSPL IL23R BORA | 9.11e-05 | 1423 | 159 | 25 | GO:0051174 |
| GeneOntologyBiologicalProcess | heterochromatin organization | 1.21e-04 | 13 | 159 | 3 | GO:0070828 | |
| GeneOntologyBiologicalProcess | neuron projection development | KIF13B FAT4 NEUROD4 TRPC6 SMURF1 CDH23 ADGRV1 PAK6 SHOC2 CSMD3 LIFR JUN HMCN2 ALMS1 MYO3B TRPV2 KNDC1 AUTS2 CPNE1 MINAR1 FLRT3 LGR6 EMX1 | 1.37e-04 | 1285 | 159 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | CEACAM5 DUSP7 CEACAM6 CTDSP1 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN CTDSPL | 1.63e-04 | 375 | 159 | 11 | GO:0001933 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | ERBB4 CEACAM5 RIPK1 TRPC6 DUSP7 CEACAM6 CTDSP1 TAB2 TRIM65 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN LRRN3 KNDC1 FGR CTDSPL IL23R BORA | 1.71e-04 | 1133 | 159 | 21 | GO:0001932 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | ERBB4 CEACAM5 RIPK1 TRPC6 DUSP7 CEACAM6 CTDSP1 TAB2 TRIM65 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN LRRN3 KCTD20 KNDC1 FGR CTDSPL IL23R BORA | 1.87e-04 | 1226 | 159 | 22 | GO:0042325 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.91e-04 | 15 | 159 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.91e-04 | 15 | 159 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 2.34e-04 | 16 | 159 | 3 | GO:0061029 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.52e-04 | 73 | 159 | 5 | GO:0060119 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | CEACAM5 DUSP7 CEACAM6 CTDSP1 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN CTDSPL | 2.89e-04 | 401 | 159 | 11 | GO:0042326 |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | ERBB4 CEACAM5 TANK RIPK1 FNTA TRPC6 CEACAM6 TAB2 TRIM65 PTPN22 HUWE1 TGFB1 LRRN3 NFE2 PAXIP1 KNDC1 IL23R BORA | 3.35e-04 | 937 | 159 | 18 | GO:0031401 |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 3.51e-04 | 4 | 159 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.51e-04 | 4 | 159 | 2 | GO:0070433 | |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.51e-04 | 4 | 159 | 2 | GO:0070425 | |
| GeneOntologyBiologicalProcess | gland development | ERBB4 CEACAM5 CEACAM6 FOXA1 FOXA3 TGFB1 ARHGAP5 JUN HOXB3 SULF2 SULF1 PKD1 CSMD1 | 3.99e-04 | 558 | 159 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.69e-04 | 47 | 159 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 4.70e-04 | 178 | 159 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.78e-04 | 128 | 159 | 6 | GO:0072009 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 5.37e-04 | 182 | 159 | 7 | GO:0002761 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 5.50e-04 | 49 | 159 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA processing | 5.82e-04 | 5 | 159 | 2 | GO:1903800 | |
| GeneOntologyBiologicalProcess | positive regulation of protein oligomerization | 5.82e-04 | 5 | 159 | 2 | GO:0032461 | |
| GeneOntologyBiologicalProcess | protein farnesylation | 5.82e-04 | 5 | 159 | 2 | GO:0018343 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 5.94e-04 | 50 | 159 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | cartilage development | 6.09e-04 | 243 | 159 | 8 | GO:0051216 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 6.22e-04 | 22 | 159 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | CEACAM5 DUSP7 CEACAM6 CTDSP1 PTPN22 SIRPA GPRC5A CTDSP2 TGFB1 JUN MINAR1 CTDSPL | 6.33e-04 | 512 | 159 | 12 | GO:0031400 |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 6.90e-04 | 52 | 159 | 4 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.11e-04 | 23 | 159 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 7.11e-04 | 23 | 159 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 7.38e-04 | 139 | 159 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 7.42e-04 | 53 | 159 | 4 | GO:0016339 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.08e-04 | 24 | 159 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.08e-04 | 24 | 159 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | FAT4 ERBB4 CEACAM5 FNTA MTSS1 SMURF1 CEACAM6 GPRC5A SHOC2 ERBIN TFAP2B TGFB1 LIFR JUN SULF2 SULF1 FLRT3 FGR PRDM16 DKK3 | 8.17e-04 | 1186 | 159 | 20 | GO:0007167 |
| GeneOntologyBiologicalProcess | metanephros development | 8.47e-04 | 95 | 159 | 5 | GO:0001656 | |
| GeneOntologyBiologicalProcess | neuron development | KIF13B FAT4 NEUROD4 TRPC6 SMURF1 CDH23 ADGRV1 PAK6 SHOC2 CSMD3 LIFR JUN HMCN2 ALMS1 MYO3B TRPV2 KNDC1 AUTS2 CPNE1 MINAR1 FLRT3 LGR6 EMX1 | 8.54e-04 | 1463 | 159 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | KIF13B TRPC6 SMURF1 CDH23 PAK6 TGFB1 ENAM LIFR CDH20 HMCN2 MYO3B TRPV2 KNDC1 AUTS2 CPNE1 FLRT3 LGR6 FGR EMX1 CDH8 | 8.87e-04 | 1194 | 159 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 8.88e-04 | 96 | 159 | 5 | GO:0060113 | |
| GeneOntologyBiologicalProcess | epithelium development | AMPD2 FAT4 ERBB4 TBX4 CEACAM5 MTSS1 CDH23 CEACAM6 FOXA1 FOXA3 TFAP2B TGFB1 GREB1L ENAM JUN ALMS1 SULF1 MYO3B PKD1 FLRT3 SNAI1 CSMD1 EMX1 | 9.03e-04 | 1469 | 159 | 23 | GO:0060429 |
| GeneOntologyBiologicalProcess | surfactant homeostasis | 9.13e-04 | 25 | 159 | 3 | GO:0043129 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 9.13e-04 | 25 | 159 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 9.14e-04 | 56 | 159 | 4 | GO:0002418 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.43e-09 | 16 | 161 | 6 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin complex | 1.65e-08 | 59 | 161 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 2.98e-08 | 25 | 161 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 6.22e-08 | 28 | 161 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | protein farnesyltransferase complex | 1.76e-04 | 3 | 161 | 2 | GO:0005965 | |
| Domain | Myosin_head_motor_dom | 1.06e-09 | 38 | 162 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.06e-09 | 38 | 162 | 8 | PS51456 | |
| Domain | Myosin_head | 1.06e-09 | 38 | 162 | 8 | PF00063 | |
| Domain | MYSc | 1.06e-09 | 38 | 162 | 8 | SM00242 | |
| Domain | Myosin_N | 1.82e-09 | 15 | 162 | 6 | PF02736 | |
| Domain | Myosin_N | 1.82e-09 | 15 | 162 | 6 | IPR004009 | |
| Domain | Myosin_tail_1 | 6.61e-09 | 18 | 162 | 6 | PF01576 | |
| Domain | Myosin_tail | 6.61e-09 | 18 | 162 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 9.59e-09 | 19 | 162 | 6 | IPR027401 | |
| Domain | - | 9.59e-09 | 19 | 162 | 6 | 4.10.270.10 | |
| Domain | IQ | 1.80e-07 | 71 | 162 | 8 | PF00612 | |
| Domain | Cadherin_CS | 4.52e-07 | 109 | 162 | 9 | IPR020894 | |
| Domain | IQ | 5.06e-07 | 81 | 162 | 8 | SM00015 | |
| Domain | CADHERIN_1 | 6.15e-07 | 113 | 162 | 9 | PS00232 | |
| Domain | Cadherin | 6.15e-07 | 113 | 162 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 6.62e-07 | 114 | 162 | 9 | PS50268 | |
| Domain | - | 6.62e-07 | 114 | 162 | 9 | 2.60.40.60 | |
| Domain | CA | 7.13e-07 | 115 | 162 | 9 | SM00112 | |
| Domain | Cadherin-like | 7.68e-07 | 116 | 162 | 9 | IPR015919 | |
| Domain | Cadherin | 8.87e-07 | 118 | 162 | 9 | IPR002126 | |
| Domain | IQ_motif_EF-hand-BS | 1.14e-06 | 90 | 162 | 8 | IPR000048 | |
| Domain | IQ | 1.47e-06 | 93 | 162 | 8 | PS50096 | |
| Domain | HECT | 3.19e-06 | 27 | 162 | 5 | PF00632 | |
| Domain | HECTc | 3.19e-06 | 27 | 162 | 5 | SM00119 | |
| Domain | HECT_dom | 3.19e-06 | 27 | 162 | 5 | IPR000569 | |
| Domain | HECT | 3.19e-06 | 27 | 162 | 5 | PS50237 | |
| Domain | Dullard_phosphatase | 6.32e-06 | 5 | 162 | 3 | IPR011948 | |
| Domain | CPDc | 3.47e-05 | 8 | 162 | 3 | SM00577 | |
| Domain | FCP1 | 3.47e-05 | 8 | 162 | 3 | PS50969 | |
| Domain | NIF | 5.18e-05 | 9 | 162 | 3 | PF03031 | |
| Domain | FCP1_dom | 5.18e-05 | 9 | 162 | 3 | IPR004274 | |
| Domain | Extracellular_sulfatase | 7.48e-05 | 2 | 162 | 2 | IPR014615 | |
| Domain | Extracellular_sulfatase_C | 7.48e-05 | 2 | 162 | 2 | IPR024609 | |
| Domain | DUF3740 | 7.48e-05 | 2 | 162 | 2 | PF12548 | |
| Domain | LRR_8 | 1.25e-04 | 171 | 162 | 8 | PF13855 | |
| Domain | LRR_TYP | 1.59e-04 | 177 | 162 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.59e-04 | 177 | 162 | 8 | IPR003591 | |
| Domain | GPS | 2.06e-04 | 34 | 162 | 4 | SM00303 | |
| Domain | Fork-head_N | 2.23e-04 | 3 | 162 | 2 | IPR013638 | |
| Domain | Forkhead_box_C | 2.23e-04 | 3 | 162 | 2 | IPR018533 | |
| Domain | Forkhead_N | 2.23e-04 | 3 | 162 | 2 | PF08430 | |
| Domain | HNF_C | 2.23e-04 | 3 | 162 | 2 | PF09354 | |
| Domain | GPS | 2.32e-04 | 35 | 162 | 4 | PF01825 | |
| Domain | GPS | 2.59e-04 | 36 | 162 | 4 | PS50221 | |
| Domain | GPS | 2.88e-04 | 37 | 162 | 4 | IPR000203 | |
| Domain | PC1 | 4.44e-04 | 4 | 162 | 2 | IPR000434 | |
| Domain | CUB | 8.53e-04 | 49 | 162 | 4 | PF00431 | |
| Domain | CUB | 9.21e-04 | 50 | 162 | 4 | SM00042 | |
| Domain | C2 | 9.94e-04 | 131 | 162 | 6 | PF00168 | |
| Domain | - | 1.07e-03 | 52 | 162 | 4 | 2.60.120.290 | |
| Domain | Sushi | 1.07e-03 | 52 | 162 | 4 | PF00084 | |
| Domain | CUB | 1.15e-03 | 53 | 162 | 4 | PS01180 | |
| Domain | LRRNT | 1.15e-03 | 53 | 162 | 4 | PF01462 | |
| Domain | CCP | 1.23e-03 | 54 | 162 | 4 | SM00032 | |
| Domain | C2 | 1.25e-03 | 137 | 162 | 6 | SM00239 | |
| Domain | SUSHI | 1.41e-03 | 56 | 162 | 4 | PS50923 | |
| Domain | C2 | 1.51e-03 | 142 | 162 | 6 | PS50004 | |
| Domain | Sushi_SCR_CCP_dom | 1.51e-03 | 57 | 162 | 4 | IPR000436 | |
| Domain | CUB_dom | 1.51e-03 | 57 | 162 | 4 | IPR000859 | |
| Domain | PKD | 1.53e-03 | 7 | 162 | 2 | PF00801 | |
| Domain | LRRNT | 1.64e-03 | 98 | 162 | 5 | IPR000372 | |
| Domain | LRRNT | 1.64e-03 | 98 | 162 | 5 | SM00013 | |
| Domain | - | 1.86e-03 | 148 | 162 | 6 | 2.60.40.150 | |
| Domain | LRR | 1.89e-03 | 201 | 162 | 7 | PS51450 | |
| Domain | L_dom-like | 2.30e-03 | 328 | 162 | 9 | IPR032675 | |
| Domain | - | 2.31e-03 | 64 | 162 | 4 | 3.40.50.1000 | |
| Domain | Leu-rich_rpt | 2.56e-03 | 271 | 162 | 8 | IPR001611 | |
| Domain | Copine | 2.59e-03 | 9 | 162 | 2 | PF07002 | |
| Domain | Copine | 2.59e-03 | 9 | 162 | 2 | IPR010734 | |
| Domain | LRR_1 | 3.05e-03 | 219 | 162 | 7 | PF00560 | |
| Domain | C2_dom | 3.10e-03 | 164 | 162 | 6 | IPR000008 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.01e-05 | 70 | 113 | 6 | M12294 | |
| Pathway | PID_BMP_PATHWAY | 2.03e-05 | 42 | 113 | 5 | M181 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.00e-14 | 6 | 164 | 6 | 10077619 | |
| Pubmed | 6.99e-14 | 7 | 164 | 6 | 35210422 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.19e-12 | 5 | 164 | 5 | 3829126 | |
| Pubmed | 2.19e-12 | 5 | 164 | 5 | 6196357 | ||
| Pubmed | 1.31e-11 | 6 | 164 | 5 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.31e-11 | 6 | 164 | 5 | 10588881 | |
| Pubmed | 4.57e-11 | 7 | 164 | 5 | 16819597 | ||
| Pubmed | TAB2 ADGRV1 ERBIN KMT2C SULF2 AATK SMG7 ALMS1 UBR5 SEC16A AUTS2 MINAR1 PRDM16 | 6.36e-11 | 225 | 164 | 13 | 12168954 | |
| Pubmed | 4.77e-10 | 4 | 164 | 4 | 20357587 | ||
| Pubmed | 4.77e-10 | 4 | 164 | 4 | 1985022 | ||
| Pubmed | 4.77e-10 | 4 | 164 | 4 | 10388558 | ||
| Pubmed | Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. | 4.77e-10 | 4 | 164 | 4 | 19004823 | |
| Pubmed | PITPNM2 RNF44 MTSS1 SMPD4 ADGRV1 DDX55 SHOC2 KMT2C SULF2 SMG7 SULF1 NAT10 AUTS2 CPNE1 FLRT3 CEP126 ADGRL2 | 6.62e-10 | 529 | 164 | 17 | 14621295 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.37e-09 | 5 | 164 | 4 | 12919077 | |
| Pubmed | 2.37e-09 | 5 | 164 | 4 | 32973332 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.74e-09 | 13 | 164 | 5 | 8404542 | |
| Pubmed | 2.74e-09 | 13 | 164 | 5 | 8948582 | ||
| Pubmed | 4.24e-09 | 14 | 164 | 5 | 27184118 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.65e-08 | 7 | 164 | 4 | 29758057 | |
| Pubmed | 2.88e-08 | 39 | 164 | 6 | 38690566 | ||
| Pubmed | 3.29e-08 | 8 | 164 | 4 | 3864153 | ||
| Pubmed | 5.41e-08 | 22 | 164 | 5 | 24301466 | ||
| Pubmed | DCHS2 TANK ATXN7L1 PTPN22 ADGRV1 PAK6 AATK CDH20 MYO3B AUTS2 ARHGAP28 PLD5 CSMD1 MYO15A ADGRL2 EMX2 SHISA6 RASAL2 | 6.63e-08 | 814 | 164 | 18 | 23251661 | |
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 8.04e-08 | 46 | 164 | 6 | 28827394 | |
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 9.79e-08 | 10 | 164 | 4 | 8950513 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 31774910 | ||
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 17085434 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 1.03e-07 | 3 | 164 | 3 | 26059207 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 12906867 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.33e-07 | 26 | 164 | 5 | 26949039 | |
| Pubmed | 1.53e-07 | 11 | 164 | 4 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.53e-07 | 11 | 164 | 4 | 16024798 | |
| Pubmed | 3.98e-07 | 32 | 164 | 5 | 33732701 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 4.10e-07 | 4 | 164 | 3 | 18417546 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 11023856 | ||
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 16882717 | ||
| Pubmed | The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling. | 4.10e-07 | 4 | 164 | 3 | 8599089 | |
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 4.10e-07 | 4 | 164 | 3 | 11029314 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 25483191 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 4.68e-07 | 33 | 164 | 5 | 32094117 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 HIVEP2 ATXN7L1 WWP2 KAT6A SMURF1 ADGRV1 HUWE1 ERBIN LRCH3 KMT2C SMG7 NUP210 NAT10 TBCK KNDC1 AUTS2 ZFHX3 MICAL3 CSMD1 CTDSPL AFF4 XPO7 | 5.82e-07 | 1489 | 164 | 23 | 28611215 |
| Pubmed | SMPD4 CTDSP1 TAB2 PTPN22 HUWE1 PTPN21 SHOC2 ERBIN ESF1 CTDSP2 ITPR3 ARHGAP5 SMG7 NUP210 NAT10 SEC16A MICAL3 ADGRL2 CTDSPL | 5.97e-07 | 1049 | 164 | 19 | 27880917 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 6.25e-07 | 15 | 164 | 4 | 24852826 | |
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 6879174 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 1.02e-06 | 5 | 164 | 3 | 30737693 | |
| Pubmed | 1.08e-06 | 17 | 164 | 4 | 16124007 | ||
| Pubmed | TBX4 HIVEP2 NEUROD4 RNF44 OSR2 CTDSP1 FOXA1 TFAP2B CTDSP2 KMT2C JUN ZFHX3 SNAI1 EMX2 PRDM16 | 1.51e-06 | 709 | 164 | 15 | 22988430 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 22210897 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 2.04e-06 | 6 | 164 | 3 | 17559643 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 20417199 | ||
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 16059920 | ||
| Pubmed | 4.72e-06 | 197 | 164 | 8 | 23686814 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 5.12e-06 | 265 | 164 | 9 | 19240061 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PITPNM2 HIVEP2 FNTB KAT6A ZNF395 HUWE1 ARHGEF11 CTDSP2 ITPR3 KMT2C JUN AATK PKD1 SEC16A PAXIP1 MICAL3 DTX2 PRDM16 | 5.27e-06 | 1105 | 164 | 18 | 35748872 |
| Pubmed | ERBB4 MAP4K3 CTDSP1 ERBIN LRCH3 ARHGAP5 SEC16A MICAL3 ADGRL2 CTDSPL RASAL2 | 5.63e-06 | 421 | 164 | 11 | 36976175 | |
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 5.67e-06 | 8 | 164 | 3 | 14667415 | |
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 26993635 | ||
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 33667029 | ||
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 36200826 | ||
| Pubmed | 6.90e-06 | 56 | 164 | 5 | 23934736 | ||
| Pubmed | 7.69e-06 | 27 | 164 | 4 | 37995181 | ||
| Pubmed | 8.21e-06 | 58 | 164 | 5 | 21884692 | ||
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 31960486 | ||
| Pubmed | Valproic acid-induced changes in gene expression during neurulation in a mouse model. | 8.47e-06 | 9 | 164 | 3 | 9098922 | |
| Pubmed | The expression of myosin genes in developing skeletal muscle in the mouse embryo. | 1.21e-05 | 10 | 164 | 3 | 2211821 | |
| Pubmed | 1.21e-05 | 10 | 164 | 3 | 19506036 | ||
| Pubmed | 1.21e-05 | 10 | 164 | 3 | 12196586 | ||
| Pubmed | 1.21e-05 | 10 | 164 | 3 | 12721286 | ||
| Pubmed | 1.21e-05 | 10 | 164 | 3 | 26705332 | ||
| Pubmed | 1.36e-05 | 31 | 164 | 4 | 9169087 | ||
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 18310078 | ||
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 22773947 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 1.65e-05 | 11 | 164 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 1.65e-05 | 11 | 164 | 3 | 29168801 | |
| Pubmed | 1.75e-05 | 33 | 164 | 4 | 19834762 | ||
| Pubmed | 2.04e-05 | 117 | 164 | 6 | 22174793 | ||
| Pubmed | FAT4 MYH13 HUWE1 GPRC5A ERBIN ESF1 CTDSP2 CD5 UBR5 SEC16A ZFHX3 ADGRL2 RASAL2 XPO7 | 2.07e-05 | 777 | 164 | 14 | 35844135 | |
| Pubmed | 2.20e-05 | 12 | 164 | 3 | 1612587 | ||
| Pubmed | Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development. | 2.20e-05 | 12 | 164 | 3 | 28600496 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 2.21e-05 | 2 | 164 | 2 | 9585413 | |
| Pubmed | HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. | 2.21e-05 | 2 | 164 | 2 | 16192265 | |
| Pubmed | Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality. | 2.21e-05 | 2 | 164 | 2 | 28657777 | |
| Pubmed | SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. | 2.21e-05 | 2 | 164 | 2 | 24726914 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20489148 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 37964360 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20394677 | ||
| Pubmed | SULFs in human neoplasia: implication as progression and prognosis factors. | 2.21e-05 | 2 | 164 | 2 | 21599997 | |
| Pubmed | PRDM16 functions as a suppressor of lung adenocarcinoma metastasis. | 2.21e-05 | 2 | 164 | 2 | 30683132 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 2.21e-05 | 2 | 164 | 2 | 9382868 | |
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 2.21e-05 | 2 | 164 | 2 | 22337492 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21699750 | ||
| Pubmed | Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. | 2.21e-05 | 2 | 164 | 2 | 20479257 | |
| Pubmed | Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13. | 2.21e-05 | 2 | 164 | 2 | 20602915 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 2.21e-05 | 2 | 164 | 2 | 24408017 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28077374 | ||
| Pubmed | The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease. | 2.21e-05 | 2 | 164 | 2 | 32558243 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15248757 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 34489650 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 38502695 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 11834739 | ||
| Interaction | ABTB2 interactions | 1.31e-07 | 101 | 163 | 9 | int:ABTB2 | |
| Interaction | TLE3 interactions | MYH1 MYH2 MYH3 MYH4 CRTC3 MYH8 HIVEP2 OSR2 FOXA1 FOXA3 SMG7 UBR5 AUTS2 ZFHX3 | 2.38e-06 | 376 | 163 | 14 | int:TLE3 |
| Interaction | GSC interactions | 6.76e-06 | 87 | 163 | 7 | int:GSC | |
| Interaction | RSPH6A interactions | 7.49e-06 | 34 | 163 | 5 | int:RSPH6A | |
| Interaction | ASAH2 interactions | 1.02e-05 | 6 | 163 | 3 | int:ASAH2 | |
| Interaction | HSPB8 interactions | 1.13e-05 | 172 | 163 | 9 | int:HSPB8 | |
| Interaction | TSPAN33 interactions | 1.42e-05 | 65 | 163 | 6 | int:TSPAN33 | |
| Interaction | USP29 interactions | 3.86e-05 | 24 | 163 | 4 | int:USP29 | |
| Cytoband | 17p13.1 | 7.12e-05 | 118 | 165 | 5 | 17p13.1 | |
| Cytoband | 8p11 | 7.67e-05 | 4 | 165 | 2 | 8p11 | |
| Cytoband | 3q29 | 2.37e-04 | 83 | 165 | 4 | 3q29 | |
| Cytoband | 5q31 | 8.16e-04 | 115 | 165 | 4 | 5q31 | |
| GeneFamily | Myosin heavy chains | 3.08e-10 | 15 | 117 | 6 | 1098 | |
| GeneFamily | Cadherin related | 3.71e-06 | 17 | 117 | 4 | 24 | |
| GeneFamily | CTD family phosphatases | 1.44e-05 | 8 | 117 | 3 | 1041 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.05e-04 | 57 | 117 | 4 | 1179 | |
| GeneFamily | Copines | 1.45e-03 | 9 | 117 | 2 | 829 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | CPNE8 ZNF395 ADGRV1 FOXA1 TGFB1 LIFR ARHGAP5 JUN LRRN3 FAT2 SULF2 C6orf118 SULF1 FLRT3 CEP126 CSGALNACT1 DKK3 SHISA6 | 1.75e-08 | 574 | 161 | 18 | M39056 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | ERBB4 ABCA3 FOXA1 CSMD2 C6orf118 AATK ARHGAP28 ZFHX3 FLRT3 CEP126 CSMD1 MPPED2 CDH8 DKK3 | 3.70e-06 | 513 | 161 | 14 | M39069 |
| Coexpression | BENPORATH_SUZ12_TARGETS | DCHS2 ERBB4 TRPC6 OSR2 CDH23 FOXA1 CSMD3 PIGZ GREB1L SLCO5A1 JUN HOXB3 ADAMTS18 SORCS3 ZFHX3 CSMD1 EMX1 EMX2 ELMOD1 SHISA6 | 5.97e-06 | 1035 | 161 | 20 | M9898 |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.15e-06 | 20 | 161 | 4 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 7.56e-06 | 21 | 161 | 4 | MM1102 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | KIF13B ERBB4 HIVEP2 MAP4K3 JUN ADGRL2 MPPED2 CSGALNACT1 AFF4 | 1.86e-05 | 240 | 161 | 9 | M39236 |
| Coexpression | BENPORATH_EED_TARGETS | DCHS2 ERBB4 MTSS1 CDH23 CSMD3 PIGZ TFAP2B GREB1L SLCO5A1 JUN HOXB3 AUTS2 ADAMTS18 SORCS3 ZFHX3 CSMD1 EMX2 ELMOD1 SHISA6 | 2.89e-05 | 1059 | 161 | 19 | M7617 |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | 3.46e-05 | 200 | 161 | 8 | M3236 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL | 4.88e-05 | 33 | 161 | 4 | M45764 | |
| Coexpression | BENPORATH_PRC2_TARGETS | DCHS2 ERBB4 CDH23 CSMD3 PIGZ SLCO5A1 JUN HOXB3 ADAMTS18 SORCS3 ZFHX3 CSMD1 ELMOD1 SHISA6 | 5.14e-05 | 650 | 161 | 14 | M8448 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ABCA3 MTSS1 SMURF1 CSMD2 CSMD3 FSIP2 LRRN3 FAT2 AATK AUTS2 SORCS3 ZFHX3 MICAL3 CEP126 CSMD1 MPPED2 CDH8 CSGALNACT1 RASAL2 | 5.19e-05 | 1106 | 161 | 19 | M39071 |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_PARTIAL | 7.18e-05 | 164 | 161 | 7 | M2502 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | ERBB4 CTDSP1 ADGRV1 FOXA1 ARHGAP5 FAT2 SULF2 C6orf118 CEP126 MPPED2 | 8.95e-05 | 364 | 161 | 10 | M39057 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 9.34e-05 | 171 | 161 | 7 | M39234 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.05e-04 | 300 | 161 | 9 | M8702 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | FAT4 OSR2 CTDSP1 ADGRV1 ERBIN ITPR3 TGFB1 SLCO5A1 SULF2 ADAMTS18 ARHGAP28 MINAR1 PLD5 SNAI1 EMX1 EMX2 PRDM16 SHISA6 | 1.13e-04 | 1074 | 161 | 18 | M1941 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | MYH1 MYH3 FAT4 HIVEP2 DUSP7 PCDHB7 TEX15 ADGRV1 FOXA1 JUN SULF2 TMTC4 SULF1 ADAMTS18 ARHGAP28 ZFHX3 DTX2 FLRT3 ADGRL2 | 8.43e-06 | 791 | 160 | 19 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | NEUROD4 ADGRV1 FOXA3 TFAP2B GREB1L FSIP2 C6orf118 SULF1 MYO3B ADAMTS18 PLD5 EMX1 EMX2 CDH8 | 2.51e-05 | 497 | 160 | 14 | PCBC_ECTO_fibroblast_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 3.16e-05 | 80 | 160 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.53e-05 | 120 | 160 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | MYH3 FAT4 HIVEP2 PCDHB7 TEX15 FOXA1 TMTC4 SULF1 ADAMTS18 ARHGAP28 ZFHX3 ADGRL2 | 3.97e-05 | 388 | 160 | 12 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_500 | 4.76e-05 | 86 | 160 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-3 | TANK CCR9 SIRPA PTPN21 SLCO5A1 LIFR ARHGAP5 SULF2 ARHGAP28 MICAL3 FGR RASAL2 | 8.10e-05 | 418 | 160 | 12 | GSM854291_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 8.19e-05 | 137 | 160 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | CPNE8 FAT4 MYH8 TRPC6 TEX15 GREB1L SULF1 PLD5 ADGRL2 EMX2 CSGALNACT1 | 8.67e-05 | 357 | 160 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 9.57e-05 | 189 | 160 | 8 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_500 | NEUROD4 ADGRV1 FOXA3 TFAP2B GREB1L FSIP2 C6orf118 SULF1 MYO3B ADAMTS18 EMX1 EMX2 CDH8 | 1.00e-04 | 495 | 160 | 13 | PCBC_ECTO_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 1.07e-04 | 143 | 160 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FAT4 CRTC3 HIVEP2 FNTB DUSP7 MTSS1 CTDSP1 TRIM65 ZNF395 PTPN21 ARHGEF11 GREB1L SULF2 NFE2 SULF1 PKD1 SEC16A CERCAM ARHGAP28 FLRT3 SNAI1 DKK3 | 1.10e-04 | 1208 | 160 | 22 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | CPNE8 FAT4 MYH8 TRPC6 ZNF395 TEX15 GREB1L JUN SULF2 C6orf118 SULF1 ARHGAP28 PLD5 ADGRL2 EMX2 CSGALNACT1 SHISA6 | 1.12e-04 | 797 | 160 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | FAT4 TBX4 OSR2 TFAP2B SLCO5A1 SULF1 AUTS2 ADAMTS18 ZFHX3 FLRT3 MPPED2 | 1.40e-04 | 377 | 160 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | NEUROD4 ADGRV1 PAK6 FOXA3 TFAP2B GREB1L FSIP2 C6orf118 CDH20 NFE2 SULF1 MYO3B NUP210 ADAMTS18 PLD5 FLRT3 EMX1 EMX2 CDH8 | 1.75e-04 | 991 | 160 | 19 | PCBC_ECTO_fibroblast_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | FAT4 ERBB4 TBX4 NEUROD4 OSR2 GPRC5A FOXA1 TFAP2B HOXB3 LRRN3 C6orf118 CDH20 SULF1 ADAMTS18 CERCAM ZFHX3 FLRT3 EMX2 PRDM16 | 1.82e-04 | 994 | 160 | 19 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 2.30e-04 | 40 | 160 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_500 | 2.42e-04 | 74 | 160 | 5 | gudmap_developingKidney_e15.5_S-shaped body_500_k5 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | NEUROD4 TFAP2B GREB1L FSIP2 C6orf118 CDH20 SULF1 MYO3B ADAMTS18 ZFHX3 FLRT3 EMX2 | 2.46e-04 | 471 | 160 | 12 | ratio_ECTO_vs_SC_1000_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 2.57e-04 | 75 | 160 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k4 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#1 | NEUROD4 TFAP2B GREB1L FSIP2 C6orf118 MYO3B ADAMTS18 FLRT3 EMX2 | 2.75e-04 | 279 | 160 | 9 | ratio_ECTO_vs_SC_500_K1 |
| CoexpressionAtlas | alpha beta T cells, NKT.4+.Sp, TCRb aGalCer-loaded CD1d-tetramer CD4, Spleen, avg-2 | 2.91e-04 | 77 | 160 | 5 | GSM538323_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11b+.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b+, Lymph Node, avg-3 | TANK ATXN7L1 SMURF1 SIRPA PTPN21 SLCO5A1 ARHGAP5 SULF2 ARHGAP28 MICAL3 RASAL2 | 2.95e-04 | 411 | 160 | 11 | GSM538274_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4 | 3.41e-04 | 351 | 160 | 10 | GSM538325_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.43e-04 | 123 | 160 | 6 | gudmap_developingKidney_e15.5_S-shaped body_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | CPNE8 FAT4 MYH8 OSR2 ZNF395 TEX15 GREB1L JUN SULF2 C6orf118 SULF1 PLD5 FLRT3 EMX2 CSGALNACT1 SHISA6 | 3.53e-04 | 797 | 160 | 16 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MYH3 FAT4 MYH8 TBX4 ATXN7L1 WWP2 PCDHB7 HUWE1 FOXA1 SLCO5A1 TMTC4 SULF1 TRPV2 ADAMTS18 ARHGAP28 DKK3 | 4.00e-04 | 806 | 160 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | MASP1 RNF44 ADGRV1 FOXA1 ESF1 SLCO5A1 ALMS1 UBR5 NUP210 EMX2 CDH8 RASAL2 | 4.06e-04 | 498 | 160 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500 | ERBB4 TBX4 GPRC5A FOXA1 TFAP2B HOXB3 C6orf118 SULF1 ADAMTS18 ZFHX3 FLRT3 PRDM16 | 4.06e-04 | 498 | 160 | 12 | PCBC_ratio_EB_vs_SC_500 |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#4_top-relative-expression-ranked_100 | 4.67e-04 | 48 | 160 | 4 | gudmap_developingKidney_e11.5_ureteric bud_100_k4 | |
| CoexpressionAtlas | e10.5_Emin_MedialNasal_top-relative-expression-ranked_500_3 | 4.84e-04 | 240 | 160 | 8 | Facebase_ST1_e10.5_Emin_MedialNasal_500_3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_1000 | MARCHF10 NEUROD4 ADGRV1 FOXA3 TFAP2B GREB1L FSIP2 C6orf118 HMCN2 SULF1 MYO3B NUP210 ADAMTS18 PLD5 EMX1 EMX2 CDH8 SHISA6 | 4.93e-04 | 990 | 160 | 18 | PCBC_ECTO_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | TBX4 MARCHF10 NEUROD4 ADGRV1 FOXA1 TFAP2B FSIP2 C6orf118 CDH20 HMCN2 SULF1 ADAMTS18 SORCS3 ARHGAP28 CSMD1 EMX2 CDH8 SHISA6 | 5.05e-04 | 992 | 160 | 18 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.18e-04 | 185 | 160 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.26e-04 | 243 | 160 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | CPNE8 MYH8 TEX15 GREB1L SULF2 SULF1 PLD5 EMX2 CSGALNACT1 SHISA6 | 5.37e-04 | 372 | 160 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#5 | 5.40e-04 | 88 | 160 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K5 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | FAT4 MASP1 ERBB4 TBX4 NEUROD4 OSR2 TFAP2B GREB1L HOXB3 LRRN3 C6orf118 CDH20 SULF1 ADAMTS18 SORCS3 CERCAM ARHGAP28 ZFHX3 EMX2 | 5.98e-04 | 1094 | 160 | 19 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 6.08e-04 | 137 | 160 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.32e-04 | 138 | 160 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 6.66e-04 | 23 | 160 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k3_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | MYH3 FAT4 TBX4 PCDHB7 OSR2 FOXA1 TFAP2B SLCO5A1 SULF1 AUTS2 ADAMTS18 ZFHX3 FLRT3 MPPED2 DKK3 | 7.28e-04 | 769 | 160 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.29e-04 | 196 | 160 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.30e-04 | 94 | 160 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_200 | 7.85e-04 | 55 | 160 | 4 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k2_200 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-09 | 125 | 165 | 9 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.07e-08 | 176 | 165 | 9 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.64e-08 | 181 | 165 | 9 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.34e-08 | 186 | 165 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PITPNM2 CPNE8 MASP1 SIRPA GPRC5A ADGRL2 MPPED2 CSGALNACT1 RASAL2 | 5.01e-08 | 195 | 165 | 9 | cad21edd90bf3e2fefdf5773a59cb1a664a69ddd |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 5.24e-08 | 196 | 165 | 9 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.23e-08 | 200 | 165 | 9 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.98e-08 | 147 | 165 | 8 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.05e-07 | 175 | 165 | 8 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-07 | 178 | 165 | 8 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-07 | 182 | 165 | 8 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.24e-07 | 77 | 165 | 6 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-07 | 187 | 165 | 8 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-07 | 187 | 165 | 8 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.25e-07 | 188 | 165 | 8 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.25e-07 | 188 | 165 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.39e-07 | 129 | 165 | 7 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 189 | 165 | 8 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 189 | 165 | 8 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 189 | 165 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-07 | 189 | 165 | 8 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 189 | 165 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-07 | 190 | 165 | 8 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.92e-07 | 191 | 165 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 191 | 165 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-07 | 193 | 165 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-07 | 193 | 165 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.66e-07 | 194 | 165 | 8 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.66e-07 | 194 | 165 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.92e-07 | 195 | 165 | 8 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.92e-07 | 195 | 165 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.06e-07 | 199 | 165 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-06 | 144 | 165 | 7 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-06 | 152 | 165 | 7 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.11e-06 | 101 | 165 | 6 | cf52c93f523c5f25bd45519a1444ce7bd1d8b577 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.29e-06 | 160 | 165 | 7 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-06 | 161 | 165 | 7 | 58381131e651744b5141b202f9d6063f55432db5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.59e-06 | 163 | 165 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.81e-06 | 165 | 165 | 7 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.81e-06 | 165 | 165 | 7 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 167 | 165 | 7 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 62 | 165 | 5 | a20620a8869721ea62984c2022ee1b484b455824 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.41e-06 | 62 | 165 | 5 | ee694c06bcd924b4ddf744178ba3a99e04eed51b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-06 | 174 | 165 | 7 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-06 | 174 | 165 | 7 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-06 | 175 | 165 | 7 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.46e-06 | 177 | 165 | 7 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-06 | 179 | 165 | 7 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.80e-06 | 179 | 165 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 180 | 165 | 7 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 4.98e-06 | 180 | 165 | 7 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.35e-06 | 182 | 165 | 7 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.55e-06 | 183 | 165 | 7 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 184 | 165 | 7 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 5.96e-06 | 185 | 165 | 7 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Mega-Mast|bone_marrow / Manually curated celltypes from each tissue | 5.96e-06 | 185 | 165 | 7 | a62ebaff92f2ed27b27b32c27c89cfbe2cb35116 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.96e-06 | 185 | 165 | 7 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.17e-06 | 186 | 165 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|kidney / Disease (COVID-19 only), tissue and cell type | 6.40e-06 | 187 | 165 | 7 | 2ce8038d9d1302e850c1bb536e755598f77ba4b9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-06 | 188 | 165 | 7 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-06 | 188 | 165 | 7 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | facs-Trachea-3m-Hematologic-lymphocytic-T_cell-T_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 189 | 165 | 7 | 286fcf22a2766cf435cd22f0986b1ca007d5b75a | |
| ToppCell | facs-Trachea-3m-Hematologic-lymphocytic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 189 | 165 | 7 | 815631878564b805f3dc30877c5804c3ddb8641b | |
| ToppCell | facs-Trachea-3m-Hematologic-lymphocytic-T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 189 | 165 | 7 | 035e5af872fcb8b527fa85dbcaa56e3aaff24531 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-06 | 190 | 165 | 7 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-06 | 190 | 165 | 7 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.10e-06 | 190 | 165 | 7 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.10e-06 | 190 | 165 | 7 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.10e-06 | 190 | 165 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-06 | 190 | 165 | 7 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | 5a67ff17fb4b9eff641176dff07830c9cd73754e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | 55ab2854a02cdcfc395e49870ccb7290b5e5471d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.34e-06 | 191 | 165 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.34e-06 | 191 | 165 | 7 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 7.34e-06 | 191 | 165 | 7 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 191 | 165 | 7 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 7.60e-06 | 192 | 165 | 7 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.60e-06 | 192 | 165 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 7.86e-06 | 193 | 165 | 7 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-Treg|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.86e-06 | 193 | 165 | 7 | 6115d43017070a78d335687bd039c08f00f77029 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 193 | 165 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.86e-06 | 193 | 165 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 7.86e-06 | 193 | 165 | 7 | ebe6be10ef5de9e1da988e263106698d3db42fce | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 193 | 165 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 193 | 165 | 7 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 193 | 165 | 7 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.86e-06 | 193 | 165 | 7 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.86e-06 | 193 | 165 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-06 | 194 | 165 | 7 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 194 | 165 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-06 | 195 | 165 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.41e-06 | 195 | 165 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-06 | 195 | 165 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.41e-06 | 195 | 165 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.28e-06 | 198 | 165 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.28e-06 | 198 | 165 | 7 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| Drug | formycin triphosphate | 2.71e-09 | 51 | 162 | 8 | CID000122274 | |
| Drug | purealin | 7.83e-09 | 58 | 162 | 8 | CID006419303 | |
| Drug | fast white | 1.77e-08 | 42 | 162 | 7 | CID000024008 | |
| Drug | Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; PC3; HT_HG-U133A | FAT4 MASP1 TANK OSR2 TEX15 TFAP2B GREB1L NFE2 SULF1 ARHGAP28 CDH8 | 1.76e-07 | 197 | 162 | 11 | 5761_UP |
| Drug | S-(-)-Etomoxir | 5.90e-07 | 100 | 162 | 8 | CID000060765 | |
| Drug | candesartan cilexetil | 9.93e-07 | 145 | 162 | 9 | CID000002540 | |
| Drug | blebbistatin | 1.83e-06 | 116 | 162 | 8 | CID003476986 | |
| Drug | B0683 | 1.95e-06 | 117 | 162 | 8 | CID006398969 | |
| Drug | carvedilol | 2.37e-06 | 161 | 162 | 9 | CID000002585 | |
| Drug | 2bq7 | 2.84e-06 | 123 | 162 | 8 | CID006540267 | |
| Drug | SM-2 | 2.94e-06 | 87 | 162 | 7 | CID000486033 | |
| Drug | clenbuterol | 8.27e-06 | 142 | 162 | 8 | CID000002783 | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.18e-05 | 196 | 162 | 9 | 6065_DN | |
| Drug | oxovanadium | 2.46e-05 | 120 | 162 | 7 | CID000024411 | |
| Drug | AC1LADJ6 | 4.12e-05 | 130 | 162 | 7 | CID000486032 | |
| Drug | nifedipine | MYH1 MYH2 MYH3 MYH4 MYH8 MYH13 TRPC6 GRIK5 PKD1L3 ITPR3 MYO3B PKD1 | 4.41e-05 | 415 | 162 | 12 | CID000004485 |
| Drug | AC1NDU20 | 5.03e-05 | 2 | 162 | 2 | CID004631603 | |
| Drug | 1nl4 | 5.03e-05 | 2 | 162 | 2 | CID000447390 | |
| Drug | S4-8 | 5.03e-05 | 2 | 162 | 2 | CID015942674 | |
| Drug | 2bed | 5.03e-05 | 2 | 162 | 2 | CID009547909 | |
| Drug | ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID | 5.03e-05 | 2 | 162 | 2 | DB07895 | |
| Drug | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | 5.03e-05 | 2 | 162 | 2 | DB07771 | |
| Drug | FARNESYL | 5.03e-05 | 2 | 162 | 2 | DB07752 | |
| Drug | (20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE | 5.03e-05 | 2 | 162 | 2 | DB08674 | |
| Drug | (20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE | 5.03e-05 | 2 | 162 | 2 | DB08676 | |
| Drug | (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE | 5.03e-05 | 2 | 162 | 2 | DB07216 | |
| Drug | 3 mN | 5.03e-05 | 2 | 162 | 2 | CID011963504 | |
| Drug | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE | 5.03e-05 | 2 | 162 | 2 | DB06953 | |
| Drug | AC1NRBPQ | 5.75e-05 | 137 | 162 | 7 | CID005288569 | |
| Drug | NSC339663 | 7.90e-05 | 250 | 162 | 9 | CID000003892 | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 3711_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 8.95e-05 | 198 | 162 | 8 | 6742_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 9.26e-05 | 199 | 162 | 8 | 1502_DN | |
| Drug | gadolinium | 9.26e-05 | 199 | 162 | 8 | CID000023982 | |
| Drug | 4-chloroaniline | 1.03e-04 | 202 | 162 | 8 | CID000007812 | |
| Drug | phosphotyrosine (pY | 1.06e-04 | 203 | 162 | 8 | CID000030819 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.77e-12 | 10 | 160 | 6 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.08e-11 | 12 | 160 | 6 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.08e-11 | 12 | 160 | 6 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.85e-11 | 13 | 160 | 6 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.11e-10 | 15 | 160 | 6 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.20e-07 | 71 | 160 | 7 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 2.35e-07 | 48 | 160 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 4.99e-06 | 80 | 160 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | Mesomelia-synostoses syndrome | 2.92e-05 | 2 | 160 | 2 | C1838162 | |
| Disease | alcohol consumption measurement | CPNE8 GRIK5 ADGRV1 DDX55 PKD1L3 CSMD3 C6orf118 ALMS1 HACE1 AUTS2 ZFHX3 MICAL3 CSMD1 MYO15A ADGRL2 PRDM16 MPPED2 AFF4 XPO7 | 4.64e-05 | 1242 | 160 | 19 | EFO_0007878 |
| Disease | diet measurement | CPNE8 ERBB4 GRIK5 TEX15 PTPN21 SHOC2 TFAP2B AATK CDH20 AUTS2 SORCS3 ZFHX3 CSMD1 ADGRL2 PRDM16 CSGALNACT1 SHISA6 | 5.93e-05 | 1049 | 160 | 17 | EFO_0008111 |
| Disease | cervical carcinoma | 6.38e-05 | 182 | 160 | 7 | EFO_0001061 | |
| Disease | Bicuspid aortic valve | 8.73e-05 | 3 | 160 | 2 | HP_0001647 | |
| Disease | hydroxy-leucine measurement | 1.04e-04 | 45 | 160 | 4 | EFO_0005276 | |
| Disease | colorectal health | 1.19e-04 | 201 | 160 | 7 | EFO_0008460 | |
| Disease | colorectal cancer, inflammatory bowel disease | 1.42e-04 | 19 | 160 | 3 | EFO_0003767, MONDO_0005575 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.46e-04 | 49 | 160 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | TYPE 1 DIABETES MELLITUS | 1.74e-04 | 4 | 160 | 2 | 222100 | |
| Disease | Diabetes mellitus type 1 | 1.74e-04 | 4 | 160 | 2 | cv:C0011854 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.89e-04 | 5 | 160 | 2 | DOID:3030 (is_marker_for) | |
| Disease | atopy | 2.89e-04 | 5 | 160 | 2 | EFO_0002686 | |
| Disease | Early Pregnancy Loss | 3.27e-04 | 109 | 160 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 3.27e-04 | 109 | 160 | 5 | C0000786 | |
| Disease | Miscarriage | 3.27e-04 | 109 | 160 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 3.27e-04 | 109 | 160 | 5 | C0000822 | |
| Disease | TEMPS-A questionnaire | 3.30e-04 | 25 | 160 | 3 | EFO_0004783 | |
| Disease | carcinoma (implicated_via_orthology) | 4.11e-04 | 64 | 160 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | laryngeal carcinoma (is_marker_for) | 4.32e-04 | 6 | 160 | 2 | DOID:2600 (is_marker_for) | |
| Disease | response to surgery, post-operative sign or symptom | 4.32e-04 | 6 | 160 | 2 | EFO_0005323, EFO_0009951 | |
| Disease | schizophrenia (implicated_via_orthology) | 5.18e-04 | 68 | 160 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | smoking status measurement | CPNE8 ERBB4 WWP2 GRIK5 HOXB3 C6orf118 ALMS1 TMTC4 ZNF804B HACE1 AUTS2 SORCS3 ZFHX3 PLD5 EMX2 CDH8 | 5.94e-04 | 1160 | 160 | 16 | EFO_0006527 |
| Disease | serum IgG glycosylation measurement | CPNE8 HIVEP2 NEUROD4 MTSS1 ZNF804B HACE1 AUTS2 PLD5 CSMD1 SHISA6 | 5.98e-04 | 523 | 160 | 10 | EFO_0005193 |
| Disease | Attached earlobe | 8.01e-04 | 8 | 160 | 2 | HP_0009907 | |
| Disease | sleep duration | 8.42e-04 | 362 | 160 | 8 | EFO_0005271 | |
| Disease | coronary aneurysm | 9.02e-04 | 35 | 160 | 3 | EFO_1000881 | |
| Disease | Inflammatory Bowel Diseases | 9.02e-04 | 35 | 160 | 3 | C0021390 | |
| Disease | Behcet's disease (is_implicated_in) | 9.80e-04 | 36 | 160 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Distal arthrogryposis | 1.03e-03 | 9 | 160 | 2 | cv:C0265213 | |
| Disease | asthma, sex interaction measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0008343, MONDO_0004979 | |
| Disease | neuroticism measurement, cognitive function measurement | ERBB4 TANK PKD1L3 AATK AUTS2 CPNE1 SORCS3 ZFHX3 CSMD1 SHISA6 | 1.09e-03 | 566 | 160 | 10 | EFO_0007660, EFO_0008354 |
| Disease | obesity (implicated_via_orthology) | 1.17e-03 | 215 | 160 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.20e-03 | 85 | 160 | 4 | DOID:3910 (is_marker_for) | |
| Disease | Stomach Neoplasms | 1.23e-03 | 297 | 160 | 7 | C0038356 | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | glucagon-like peptide-1 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0008465 | |
| Disease | Malignant neoplasm of stomach | 1.30e-03 | 300 | 160 | 7 | C0024623 | |
| Disease | body weight | ERBB4 TBX4 HIVEP2 GRIK5 ADGRV1 HUWE1 PAK6 TFAP2B AATK HACE1 PKD1 AUTS2 ZFHX3 FGR MPPED2 XPO7 | 1.42e-03 | 1261 | 160 | 16 | EFO_0004338 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERBB4 TANK CDH23 TFAP2B AATK ALMS1 HACE1 AUTS2 SORCS3 ZFHX3 ADGRL2 CDH8 | 1.46e-03 | 801 | 160 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | colorectal cancer (is_marker_for) | 1.69e-03 | 157 | 160 | 5 | DOID:9256 (is_marker_for) | |
| Disease | platelet measurement | 1.72e-03 | 315 | 160 | 7 | EFO_0005036 | |
| Disease | esophagus adenocarcinoma (is_marker_for) | 1.86e-03 | 12 | 160 | 2 | DOID:4914 (is_marker_for) | |
| Disease | outer ear morphology trait | 1.86e-03 | 12 | 160 | 2 | EFO_0007664 | |
| Disease | Adenocarcinoma of large intestine | 1.88e-03 | 96 | 160 | 4 | C1319315 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.88e-03 | 45 | 160 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | opioid dependence | 1.91e-03 | 237 | 160 | 6 | EFO_0005611 | |
| Disease | dimethylglycine measurement | 2.00e-03 | 46 | 160 | 3 | EFO_0010476 | |
| Disease | smoking cessation | 2.05e-03 | 325 | 160 | 7 | EFO_0004319 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.19e-03 | 13 | 160 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | uveitis (is_implicated_in) | 2.19e-03 | 13 | 160 | 2 | DOID:13141 (is_implicated_in) | |
| Disease | colon carcinoma (is_marker_for) | 2.19e-03 | 13 | 160 | 2 | DOID:1520 (is_marker_for) | |
| Disease | gastroesophageal reflux disease | 2.26e-03 | 101 | 160 | 4 | EFO_0003948 | |
| Disease | motion sickness | 2.26e-03 | 48 | 160 | 3 | EFO_0006928 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.33e-03 | 169 | 160 | 5 | DOID:3908 (is_marker_for) | |
| Disease | malaria | 2.34e-03 | 102 | 160 | 4 | EFO_0001068 | |
| Disease | blood copper measurement | 2.54e-03 | 50 | 160 | 3 | EFO_0007578 | |
| Disease | glycodeoxycholate measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0010493 | |
| Disease | lobe size | 2.55e-03 | 14 | 160 | 2 | EFO_0007666 | |
| Disease | triacylglycerol 46:2 measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0010402 | |
| Disease | mean corpuscular hemoglobin concentration | MYH2 FNTB CTDSP1 SIRPA FOXA3 C6orf118 UBR5 NFE2 SEC16A MYO15A PRDM16 BORA DCAF12 XPO7 | 2.86e-03 | 1105 | 160 | 14 | EFO_0004528 |
| Disease | monoclonal gammopathy | 3.00e-03 | 53 | 160 | 3 | EFO_0000203 | |
| Disease | grip strength measurement | 3.09e-03 | 350 | 160 | 7 | EFO_0006941 | |
| Disease | risk-taking behaviour | TRPC6 CDH23 PKD1L3 AUTS2 SORCS3 ARHGAP28 ZFHX3 CEP126 MPPED2 CDH8 SHISA6 | 3.11e-03 | 764 | 160 | 11 | EFO_0008579 |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.15e-03 | 447 | 160 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Schizophrenia | ERBB4 GRIK5 PTPN21 CSMD2 ARHGEF11 TGFB1 LIFR JUN AUTS2 CSMD1 EMX2 DKK3 | 3.25e-03 | 883 | 160 | 12 | C0036341 |
| Disease | amygdala volume change measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0021490 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.34e-03 | 355 | 160 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | conotruncal heart malformations | 3.50e-03 | 114 | 160 | 4 | MONDO_0016581 | |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | phosphatidylcholine 40:6 measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010389 | |
| Disease | sphingomyelin 14:0 measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010390 | |
| Disease | psoriasis | 3.84e-03 | 273 | 160 | 6 | EFO_0000676 | |
| Disease | amino acid measurement | FAT4 ERBB4 WWP2 SMURF1 GRIK5 SHOC2 C6orf118 ALMS1 CSMD1 ADGRL2 | 4.02e-03 | 678 | 160 | 10 | EFO_0005134 |
| Disease | facial morphology measurement | 4.04e-03 | 466 | 160 | 8 | EFO_0007841 | |
| Disease | C-X-C motif chemokine 16 measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0010911 | |
| Disease | noggin measurement | 4.22e-03 | 18 | 160 | 2 | EFO_0021995 | |
| Disease | executive function measurement | 4.56e-03 | 376 | 160 | 7 | EFO_0009332 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 4.70e-03 | 19 | 160 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | visceral adipose tissue measurement | 4.87e-03 | 481 | 160 | 8 | EFO_0004765 | |
| Disease | ulcerative colitis, Crohn's disease | 5.21e-03 | 20 | 160 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | serum carcinoembryonic antigen measurement | 5.21e-03 | 20 | 160 | 2 | EFO_0005760 | |
| Disease | age at menarche | 5.27e-03 | 594 | 160 | 9 | EFO_0004703 | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.40e-03 | 293 | 160 | 6 | C1708349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QALDNPEYHNASNGP | 1181 | Q15303 | |
| TFAADHNYLQQLPPE | 326 | Q96RT1 | |
| YNIAPEAPTLSHFQQ | 261 | Q8N336 | |
| LSPNFPSNYDNNHEC | 1116 | Q96PZ7 | |
| RQDPLNPDQDSSSHY | 3466 | Q96PZ7 | |
| ITSPNFPIQYDNNAH | 416 | Q7Z408 | |
| IISSPSFPNEYHNNA | 251 | Q7Z407 | |
| ILLSPNYPLNYENNH | 1251 | Q7Z407 | |
| ENSPNHRPYTASDFI | 196 | Q8TDX6 | |
| NLSCHAASNPPAQYS | 256 | P06731 | |
| LNLSCHSASNPSPQY | 611 | P06731 | |
| QDINDNPPVFGSSHY | 241 | Q6V0I7 | |
| PPGQHLSDYSQLNES | 486 | Q9NWN3 | |
| DNHINRVPPNAFSYL | 256 | Q9NZU0 | |
| NPKYHPSRNNTIANF | 1341 | Q8WXG9 | |
| KPSAFYQQTLPNSHL | 866 | Q8TCU4 | |
| HFENNQQYDAPEPGT | 571 | O15085 | |
| ASHVDNEYSQPPRNS | 446 | P06127 | |
| NEYSQPPRNSHLSAY | 451 | P06127 | |
| LFNNQAYHSPATALA | 1041 | Q99758 | |
| PHIDPDNYFNANCSF | 776 | O95490 | |
| SNNSLFLSYHRNPLP | 736 | Q01433 | |
| NDNAPTFHNQPYSVR | 126 | Q9H251 | |
| AAPPYNSLSVHNSNN | 691 | Q9ULK2 | |
| LPQLLAQEHNYSSPA | 181 | Q8TE60 | |
| HLKNSYNNSQAPSPG | 1031 | Q9UHB7 | |
| YSHVNDPYSLNPLHQ | 86 | Q92481 | |
| LYAPYSTHFQLQNQP | 316 | Q8NFJ5 | |
| NHTLQADSYSPNLPK | 316 | Q9Y2R2 | |
| NPVNAGQPLHASNYE | 186 | Q14573 | |
| YTAFSLQDPFAPTQH | 791 | Q6ZW49 | |
| GLALFAPHSSRNYQQ | 691 | Q8TEM1 | |
| FTHYNINQSRFQPPH | 26 | Q15777 | |
| SNILHASASLPPEYQ | 4816 | Q99102 | |
| DNPTANSNLYILAGH | 876 | Q8IVH8 | |
| AITPLANPFVYSLHN | 286 | Q8NGR6 | |
| HAQISTSNLYLPQDP | 356 | Q9NQU5 | |
| HSPAYSFPAAIQRNQ | 591 | Q96II8 | |
| LPSLDFAINHYGQPD | 351 | Q7RTP6 | |
| PIDNFSHNQSNDPYS | 2081 | Q8NEZ4 | |
| ARPASSFAHIPNYSN | 41 | P09769 | |
| PLLQTIHFYDNPIQF | 281 | Q9HBX8 | |
| YSTLNSEHFPQPTQQ | 2561 | Q9UKN7 | |
| HQAFAPYNKPSLSGA | 241 | Q86UW9 | |
| SLDYASQPANLQFPH | 56 | Q7Z5Y7 | |
| ASLHSEPPVYANLSN | 161 | P05412 | |
| SQAIANYALVPFHDP | 71 | Q8NDA2 | |
| NLSCHAASNPPAQYS | 256 | P40199 | |
| LQYDPPSNASAFVHR | 341 | Q8NHQ9 | |
| QAPESLPFANKHLNY | 3861 | Q5CZC0 | |
| YTSHLFNLDPSDPNF | 766 | Q9H501 | |
| QEAPPHIFSISDNAY | 151 | P13535 | |
| QINHYTPQFEDHFPQ | 706 | Q9NYQ8 | |
| EAPNQLSNGFSHYSL | 341 | O43312 | |
| APPHIFSISDNAYQF | 151 | Q9UKX2 | |
| DNSPASYVFHPDNAV | 206 | Q9GZU7 | |
| QPNSNSYVNPDHLNY | 626 | Q8IYU2 | |
| HPSAQSLSQPLSAYN | 381 | Q8WXX7 | |
| HSNFLNPAAHLEPFN | 731 | Q8WXX7 | |
| QPANPTEEYAQLFAA | 46 | Q13503 | |
| PLLHNPSASINNDYF | 216 | Q96G03 | |
| LQPLSFQNPVYHLNN | 776 | Q9UJF2 | |
| APPHIFSISDNAYQF | 151 | P12882 | |
| ACQQVYNLFHPADPS | 751 | Q9BZ72 | |
| PLHPSLQLTNYSFLQ | 11 | Q8N2R0 | |
| IFSQLYLDPDQHPFS | 36 | Q9C091 | |
| PSAHTCFNQLDLPAY | 4336 | Q7Z6Z7 | |
| YEPTNFDFNLHIPVS | 96 | A0A2R8YFL7 | |
| YSNIFVTSPSPDNLH | 306 | Q9H0A0 | |
| LYSPAQPSLQALHAY | 341 | Q9NXE4 | |
| SAHSTNSLNNPQPYL | 396 | Q16825 | |
| DLNDQPPLFSQQHYK | 531 | Q6V1P9 | |
| LDVNDNPPNFSSLSY | 2656 | Q6V1P9 | |
| QQHYFNTPFQLSIAP | 176 | Q8NI37 | |
| DPHYSFNHPFSINNL | 391 | P55317 | |
| SAPLPSAAAHQQQLY | 1861 | Q92794 | |
| DNSPFVLYPLQNSSA | 556 | Q9Y5E2 | |
| QYIQDHDTPAQAAPS | 376 | Q53T59 | |
| VDNSPASYIFHPENA | 221 | O15194 | |
| LDNSPASYIFHPENA | 216 | O14595 | |
| QAHVSFLDPRQPSYN | 316 | Q5T6F0 | |
| YSLAPEAANNPNFTI | 531 | Q9HBT6 | |
| PLFSDSFQDAYIPHN | 516 | Q9P2H0 | |
| ELQDSFHLRPSPYSN | 526 | Q6UUV7 | |
| VLNPFESPSDYSNLH | 21 | Q6PGQ7 | |
| NNVRQFASHFLPPLY | 41 | P51686 | |
| PSINTYFPQNILESH | 606 | Q5VWK5 | |
| KAHQNAYALPSNYQP | 296 | P14651 | |
| TPLFRYLNPQASLSH | 126 | Q5T5N4 | |
| YFSTPTNHNLFPLNT | 401 | Q16829 | |
| PFASAENHNYFPVNS | 521 | Q8NA82 | |
| HPQYDPNTFENDVAL | 541 | P48740 | |
| FYQALNLSLPLPNFH | 136 | Q8NDX9 | |
| QYPHLAPTYAAVNAL | 146 | P49356 | |
| QVHAFQENPYTFSPD | 1681 | Q76NI1 | |
| TALNYPHPSAAEAAF | 81 | Q04741 | |
| HPLFASQQRDPSTFY | 106 | Q04743 | |
| PVPNFNSVDQHENSY | 481 | Q9NRM1 | |
| NDNAPEFLNGPYHAT | 161 | P55286 | |
| NTSHPFYPEFVRSLN | 271 | Q16478 | |
| AFSAQPLLAAPTHYA | 526 | Q5T4B2 | |
| ASSEVNLANLPPSYH | 81 | Q9UBP4 | |
| NLANLPPSYHNETNT | 86 | Q9UBP4 | |
| SHEFALNGNPQNPYC | 376 | Q86YQ8 | |
| VSHEFALNFNPSNPY | 351 | Q99829 | |
| NIPDFLSNFPNFQHD | 721 | Q3KNS1 | |
| PNQEIYNFTLNAHNP | 401 | P42702 | |
| APHLNSYQSLELPQN | 56 | E9PI22 | |
| EQALHQFQPPYNESF | 1061 | P98161 | |
| PNSLAHSNYTLPAAE | 186 | Q16621 | |
| DANDNSPFVLYPLQN | 551 | Q9Y5E3 | |
| NDNPPAFTQAQYHIN | 236 | Q9Y5H4 | |
| EKLHYPNASSQTPNF | 391 | Q9UPX6 | |
| NHSPDPGLSNLAASY | 1436 | Q9NQT8 | |
| APSQYSTRHFFQDQP | 186 | Q8N4H0 | |
| PPGTALQFYSNLHNA | 151 | Q7Z7N9 | |
| IPEGLNYSENAPFHL | 116 | Q8N7P1 | |
| PHFNPSAIHNFYDNI | 621 | Q9NYJ8 | |
| YDTFGSKFHLNPQPQ | 981 | A0AVI2 | |
| YLSNNHISQLPPSVF | 251 | Q8TF66 | |
| FELGTQPYPQHSDQQ | 331 | Q6ZMQ8 | |
| ATNNPRLSYIHPNAF | 316 | Q9H3W5 | |
| QSQLLSFSPNLDYHN | 1001 | Q9UPU3 | |
| LNQLLDLQPSHSSPY | 296 | P49354 | |
| ELKLDAPYNFNHPFS | 291 | P55318 | |
| PSLNHASLGFNEYFP | 476 | Q9HAZ2 | |
| SPPHHSGFQQYQQAD | 781 | Q92540 | |
| SELNSPAPHGQNNCY | 21 | Q7Z443 | |
| HFISPPYQIQELNAS | 216 | Q9H2Y9 | |
| ELYLNDNPNLHSLPF | 521 | Q9UQ13 | |
| APQAAEPNNHTEYAS | 441 | P78324 | |
| FSRSFQNLAHLPPSY | 286 | Q6ZSJ9 | |
| PGDHNALYVNSFPLL | 331 | Q92844 | |
| APPHIFSISDNAYQF | 151 | Q9Y623 | |
| APPHIFSISDNAYQF | 151 | P11055 | |
| DQTFLPHRSTNLQPY | 101 | Q13017 | |
| SHDPFAQQRPYENFQ | 416 | Q13546 | |
| APHLNSYQSLELPQN | 56 | P0DMB1 | |
| NPDSSINPDHLSYFH | 476 | Q9HCE7 | |
| AANPFAASFAHLLNP | 141 | Q9UKZ1 | |
| ANPNAASYHGNLAVL | 681 | Q5T4D3 | |
| NPEFTFQQPYDQAHL | 26 | O95863 | |
| FQQPYDQAHLLAAIP | 31 | O95863 | |
| YEPDHNLESNFITNP | 246 | Q6P1L6 | |
| INPASSINPDHLTYF | 591 | O00308 | |
| CQANASFSPPNIYNH | 361 | A4D1E1 | |
| SFSPPNIYNHSDARI | 366 | A4D1E1 | |
| TSLNPLQFDNPAELY | 156 | Q5JS37 | |
| AQPDHSYNLAQPINF | 831 | O15027 | |
| LTAYHSYARAQPPNA | 11 | Q9P2N2 | |
| EQLPSYRFNPDSHQS | 361 | Q7L0R7 | |
| ALYNQHNPGASAAPC | 341 | P01137 | |
| SYLLENPHQPASLQA | 226 | Q9Y5S1 | |
| ADHAYQALPSFQIPV | 406 | Q9H8N7 | |
| APPHIFSISDNAYQF | 151 | Q9UKX3 | |
| LTPVNFLHYNLNPQN | 291 | Q86VD9 | |
| YPLLEDDQSNLPHSN | 401 | Q8TEA7 | |
| ENPQSLSDPNNYHEF | 316 | Q9UIA9 | |
| PSPHLNAANEFLYSQ | 506 | P57082 | |
| EDFHLNSFNNPPRQY | 841 | Q9Y210 | |
| NFRQPIFSQYASHQP | 2741 | Q9BXT5 | |
| IFSQYASHQPLPQAT | 2746 | Q9BXT5 | |
| NFQNLASLGYPLHTP | 51 | Q32M78 | |
| PNDYVFSHLPLHSQQ | 2206 | P31629 | |
| TQPLYTFHALFNQPL | 471 | Q6PJ69 | |
| APQFSKLYPNASQHI | 231 | Q8IWU6 | |
| ASFPDQAYANSQPAA | 181 | Q9Y3P8 | |
| SAPQYSRLFPNASQH | 231 | Q8IWU5 | |
| EHPNLGSCNPSLYNT | 286 | Q9BVV6 | |
| SESEPYRNAQNPSLH | 396 | O95071 | |
| QQQQHLLFPFYIPSA | 1791 | Q15911 | |
| FDNTPLQALNLPTAY | 3101 | Q15911 | |
| TTDYGNFLANHTNPL | 51 | Q8N8Y2 | |
| HPQDPTSLGNDTLYF | 121 | Q96S16 | |
| ASNPPHIFASADAAY | 406 | Q8WXR4 | |
| AISVHNFNYQSPGLP | 196 | Q9HD90 |